92 related articles for article (PubMed ID: 19267771)
1. Are Zucker obese rats a useful model for cardiovascular complications in metabolic syndrome? Physical, biochemical and oxidative stress considerations.
Debin R; Lauzier B; Sicard P; Delemasure S; Amoureux S; Duvillard L; Vergely C; Cottin Y; Rochette L
Fundam Clin Pharmacol; 2009 Feb; 23(1):59-67. PubMed ID: 19267771
[TBL] [Abstract][Full Text] [Related]
2. Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo.
Huhn R; Heinen A; Weber NC; Kerindongo RP; Oei GT; Hollmann MW; Schlack W; Preckel B
J Pharmacol Exp Ther; 2009 May; 329(2):600-7. PubMed ID: 19244549
[TBL] [Abstract][Full Text] [Related]
3. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
[TBL] [Abstract][Full Text] [Related]
4. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
Oltman CL; Kleinschmidt TL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
Vascul Pharmacol; 2008 Jan; 48(1):47-53. PubMed ID: 18164667
[TBL] [Abstract][Full Text] [Related]
6. Experimental rat models to study the metabolic syndrome.
Aleixandre de Artiñano A; Miguel Castro M
Br J Nutr; 2009 Nov; 102(9):1246-53. PubMed ID: 19631025
[TBL] [Abstract][Full Text] [Related]
7. Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD.
Hattan N; Chilian WM; Park F; Rocic P
Basic Res Cardiol; 2007 May; 102(3):217-23. PubMed ID: 17323199
[TBL] [Abstract][Full Text] [Related]
8. Astrogliosis in the brain of obese Zucker rat: a model of metabolic syndrome.
Tomassoni D; Nwankwo IE; Gabrielli MG; Bhatt S; Muhammad AB; Lokhandwala MF; Tayebati SK; Amenta F
Neurosci Lett; 2013 May; 543():136-41. PubMed ID: 23545209
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)/IzmDmcr rats as a new model of metabolic syndrome.
Ueno T; Takagi H; Fukuda N; Takahashi A; Yao EH; Mitsumata M; Hiraoka-Yamamoto J; Ikeda K; Matsumoto K; Yamori Y
Hypertens Res; 2008 May; 31(5):1021-31. PubMed ID: 18712058
[TBL] [Abstract][Full Text] [Related]
10. Pial microvascular responses induced by transient bilateral common carotid artery occlusion in Zucker rats.
Lapi D; Mastantuono T; Sapio D; Paterni M; Colantuoni A
Clin Hemorheol Microcirc; 2013; 54(4):415-29. PubMed ID: 24002119
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats.
Poirier B; Lannaud-Bournoville M; Conti M; Bazin R; Michel O; Bariéty J; Chevalier J; Myara I
Nephrol Dial Transplant; 2000 Apr; 15(4):467-76. PubMed ID: 10727540
[TBL] [Abstract][Full Text] [Related]
12. Vitamin A status affects obesity development and hepatic expression of key genes for fuel metabolism in Zucker fatty rats.
Zhang Y; Li R; Li Y; Chen W; Zhao S; Chen G
Biochem Cell Biol; 2012 Aug; 90(4):548-57. PubMed ID: 22554462
[TBL] [Abstract][Full Text] [Related]
13. Isolated heart function after ischemia and reperfusion in sucrose-fed rats: influence of gender and treatment.
Cárdenas G; Carlos Torres J; Zamora J; Pérez I; Baños G
Clin Exp Hypertens; 2006 Feb; 28(2):85-107. PubMed ID: 16546836
[TBL] [Abstract][Full Text] [Related]
14. Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
Mingorance C; Gonzalez del Pozo M; Dolores Herrera M; Alvarez de Sotomayor M
Br J Nutr; 2009 Oct; 102(8):1145-53. PubMed ID: 19545458
[TBL] [Abstract][Full Text] [Related]
15. Site specific changes of redox metabolism in adipose tissue of obese Zucker rats.
Galinier A; Carriere A; Fernandez Y; Caspar-Bauguil S; Periquet B; Periquet A; Penicaud L; Casteilla L
FEBS Lett; 2006 Nov; 580(27):6391-8. PubMed ID: 17098232
[TBL] [Abstract][Full Text] [Related]
16. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
17. Impact of obesity on coronary microvascular function in the Zucker rat.
Prakash R; Mintz JD; Stepp DW
Microcirculation; 2006; 13(5):389-96. PubMed ID: 16815824
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic aspirin administration on an experimental model of metabolic syndrome.
Renna NF; Vazquez MA; Lama MC; González ES; Miatello RM
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):162-8. PubMed ID: 18785983
[TBL] [Abstract][Full Text] [Related]
19. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes.
Kreuz S; Schoelch C; Thomas L; Rist W; Rippmann JF; Neubauer H
Diabetes Metab Res Rev; 2009 Sep; 25(6):577-86. PubMed ID: 19618481
[TBL] [Abstract][Full Text] [Related]
20. Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome.
Bitto A; Altavilla D; Bonaiuto A; Polito F; Minutoli L; Di Stefano V; Giuliani D; Guarini S; Arcoraci V; Squadrito F
J Endocrinol; 2009 Mar; 200(3):367-76. PubMed ID: 19066292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
